• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed

    2/16/21 2:50:27 PM ET
    $CBAN
    Major Banks
    Finance
    Get the next $CBAN alert in real time by email
    SC 13D 1 colonybankcorp13djross.htm SC 13D Document

    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549
    _______________

    SCHEDULE 13D
    (Rule 13d-101)

    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    Colony Bankcorp, Inc.
    (Name of Issuer)
    Common Stock, par value $1.00 per share
    (Title of Class of Securities)
    19623P101
    (CUSIP Number)
    Jonathan W R Ross, P. O. Box 7326, Tifton, GA 31793, 229-326-0559
    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)
    November 10, 2020
    (Date of Event Which Requires Filing of this Statement)

        If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box .

        * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

        The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




    CUSIP No. 19623P101    SCHEDULE 13D

     1  
    NAMES OF REPORTING PERSONS
     
    Jonathan W.R. Ross
      2 
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a) x (b) ☐
      3 
    SEC USE ONLY
     
      4 
    SOURCE OF FUNDS (See Instructions)
     
    PF
      5 
    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
     
    ☐    
      6 
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
        7   
    SOLE VOTING POWER
     
    459,933
        8  
    SHARED VOTING POWER
     
    21,163
        9  
    SOLE DISPOSITIVE POWER
     
    459,933
      10  
    SHARED DISPOSITIVE POWER

    21,163
    11 
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    481,096
    12 
    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
     
    ☐
    13 
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     
    5.1%*
    14 
    TYPE OF REPORTING PERSON (See Instructions)

     IN

    * Based on 9,498,783 shares of the Issuer’s Common Stock outstanding as of November 9, 2020, as set forth in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2020. ☐


    CUSIP No. 19623P101    SCHEDULE 13D

     1  
    NAMES OF REPORTING PERSONS
     
    The R Sidney Ross Life Insurance Trust U/A DTD 07/06/00
      2 
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a)  x        (b)  ☐
      3 
    SEC USE ONLY
     
      4 
    SOURCE OF FUNDS (See Instructions)
     OO
      5 
    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
     
    ☐    
      6 
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Georgia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
        7   
    SOLE VOTING POWER
     
    0
        8  
    SHARED VOTING POWER
     
    21,079
        9  
    SOLE DISPOSITIVE POWER
     
    0
      10  
    SHARED DISPOSITIVE POWER
     
    21,079
    11 
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    21,079
    12 
    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
     
    ☐
    13 
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     
    0.2%*
    14 
    TYPE OF REPORTING PERSON (See Instructions)
     OO
    * Based on 9,498,783 shares of the Issuer’s Common Stock outstanding as of November 9, 2020, as set forth in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2020.


    CUSIP No. 19623P101    SCHEDULE 13D

     1  
    NAMES OF REPORTING PERSONS
     
    Jonathan W R Ross Family Trust FBO Jonathan W R Ross Family DTD 11/18/1996
      2 
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
     
    (a)  x       (b)  ☐
      3 
    SEC USE ONLY
     
      4 
    SOURCE OF FUNDS (See Instructions)
     
    OO
      5 
    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
     
    ☐    
      6 
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Georgia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
        7   
    SOLE VOTING POWER
     
    0
        8  
    SHARED VOTING POWER
     
    84
        9  
    SOLE DISPOSITIVE POWER
     
    0
      10  
    SHARED DISPOSITIVE POWER
     
    84
    11 
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    84
    12 
    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
     
    13 
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     
    0.0%*
    14 
    TYPE OF REPORTING PERSON (See Instructions)
     OO

    * Based on 9,498,783 shares of the Issuer’s Common Stock outstanding as of November 9, 2020, as set forth in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2020.



    Item 1.    Security and Issuer.
    This Schedule 13D relates to the shares of common stock, $1.00 par value (the “Common Stock”), of Colony Bankcorp, Inc., a Georgia corporation (the “Issuer”). The principal executive office of the Issuer is located at 115 South Grant Street, Fitzgerald, Georgia 31750.
    Item 2. Identity and Background.
    This Schedule 13D is jointly filed by Jonathan W.R. Ross, the R Sidney Ross Life Insurance Trust DTD 07/06/00 (the “Life Insurance Trust”) and the Jonathan W R Ross Family Trust FBO Jonathan W R Ross DTD 11/18/1996 (the “Family Trust,” and collectively, the “Reporting Persons”).
    Mr. Ross is a citizen of the United States and his present principal occupation or employment is engaging in business as the President of Ross Construction Company, which has a principal business address of P. O. Box 7326, Tifton, GA 31793. Mr. Ross is a member of the board of directors of the Issuer. The Life Insurance Trust and the Family Trust are trusts established by Mr. Ross. Mr. Ross is the sole trustee of both the Life Insurance Trust and the Family Trust.
    By virtue of these relationships and pursuant to the SEC’s beneficial ownership rules, the Reporting Persons may be deemed to be members of a group.
    The address of each Reporting Person for purposes of this filing is: P.O. Box 7326, Tifton, Georgia, 31793.
    The Reporting Persons have not, during the past five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting, or mandating activities subject to, federal or state securities laws or a finding of any violation with respect to such laws.
    Item 3. Source and Amount of Funds or Other Consideration.
    On November 10, 2020, Robert S. Ross transferred 300,000 shares of Common Stock to Mr. Ross for no consideration. The other shares of Common Stock held directly by Mr. Ross were acquired by gift or with the proceeds derived from his personal funds. The shares of Common Stock held directly by the Life Insurance Trust and the Family Trust were acquired by gift for no consideration.
    Item 4. Purpose of Transaction.

    The Reporting Persons acquired the securities of the Issuer reported herein for investment purposes.

    The shares of Common Stock reported in this Schedule 13D have been acquired for investment in the ordinary course of business. Although the Reporting Persons have no specific plan or proposal that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, consistent with its investment purpose, the Reporting Persons at any time and from time to time may acquire additional shares of Common Stock or dispose of any or all of the shares of Common Stock depending upon an ongoing evaluation of the investment in the Common Stock, prevailing market conditions, other investment opportunities, liquidity requirements of the Reporting Person, and/or other investment considerations.

    Mr. Ross is a director of the Issuer, and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

    Item 5.     Interest in Securities of the Issuer.

    All percentages are based on 9,498,783 shares of the Issuer’s Common Stock outstanding as of November 9, 2020, as set forth in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2020.



    CUSIP No. 19623P101    SCHEDULE 13D

    (a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 481,096 shares of Common Stock, representing 5.1% of the outstanding Common Stock.
    Mr. Ross beneficially owns 481,096 shares of Common Stock, which represents 5.1% of the outstanding Common Stock, the Life Insurance Trust beneficially owns 21,079 shares of Common Stock, which represents 0.2% of the outstanding Common Stock, and the Family Trust beneficially owns 84 shares of Common Stock, which represents 0.0% of the outstanding Common Stock.
    (b) With respect to any rights or powers to vote, or to direct the vote of, or to dispose of, or to direct the disposition of, the Common Stock owned by the Reporting Persons:
    (i) Sole power to vote or to direct the vote:
    Mr. Ross has the sole power to vote or to direct the vote of the 459,933 shares of Common Stock he beneficially owns.
    (ii) Shared power to vote or to direct the vote:
    Mr. Ross and the Life Insurance Trust have shared power to vote or to direct the vote of the 21,079 shares of Common Stock they beneficially own. Mr. Ross and the Family Trust have shared power to vote or to direct the vote of the 84 shares of Common Stock they beneficially own.
    (iii) Sole power to dispose or to direct the disposition of:
    Mr. Ross has the sole power to dispose or direct the disposition of the 459,933 shares of Common Stock he beneficially owns.
     
    (iv) Shared power to dispose or to direct the disposition of:
    Mr. Ross and the Life Insurance Trust have shared power to dispose or direct the disposition of the 21,079 shares of Common Stock they beneficially own. Mr. Ross and the Family Trust have shared power to dispose or direct the disposition of the 84 shares of Common Stock they beneficially own.
    (c) Other than as described herein, the Reporting Persons have not engaged in any transactions in the Common Stock in the past 60 days.
    (d) No other person has the right to receive or the power to direct the receipt of dividends, or proceeds of sale of such securities outlined in this report.
    (e) Not applicable.
    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
    Except as otherwise described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.
    Item 7. Material to Be Filed as Exhibits.
     
    Exhibit 1  
    Joint Filing Agreement, dated February 16, 2021, by and among Jonathan W. R. Ross, the R Sidney Ross Life Insurance Trust and the Jonathan W R Ross Family Trust.



        
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    Dated: February 16, 2021    
                
    JONATHAN W. R. ROSS
        
    By:    /s/ Jonathan W.R. Ross
        Jonathan W.R. Ross, Individually

    THE R SIDNEY ROSS LIFE INSURANCE TRUST

    By:     /s/ Jonathan W. R. Ross
    Name:     Jonathan W. R. Ross
    Title:     Trustee

    THE JONATHAN W R ROSS FAMILY TRUST
        
    By:     /s/ Jonathan W. R. Ross
    Name:     Jonathan W. R. Ross
    Title:     Trustee



    Get the next $CBAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBAN

    DatePrice TargetRatingAnalyst
    2/15/2023$14.00Buy → Neutral
    Janney
    1/24/2023Buy → Neutral
    DA Davidson
    7/22/2022$18.00 → $16.75Buy → Neutral
    DA Davidson
    1/12/2022$21.00Buy
    DA Davidson
    More analyst ratings

    $CBAN
    SEC Filings

    See more
    • Colony Bankcorp Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - COLONY BANKCORP INC (0000711669) (Filer)

      5/27/25 4:15:26 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - COLONY BANKCORP INC (0000711669) (Filer)

      5/23/25 4:15:21 PM ET
      $CBAN
      Major Banks
      Finance
    • SEC Form 10-Q filed by Colony Bankcorp Inc.

      10-Q - COLONY BANKCORP INC (0000711669) (Filer)

      5/9/25 10:34:16 AM ET
      $CBAN
      Major Banks
      Finance

    $CBAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHIEF BANKING OFFICER Canup Edward G bought $7,825 worth of COLONY BANKCORP (500 units at $15.65), increasing direct ownership by 3% to 16,884 units (SEC Form 4)

      4 - COLONY BANKCORP INC (0000711669) (Issuer)

      3/14/25 4:38:22 PM ET
      $CBAN
      Major Banks
      Finance
    • Bateman Leonard H Jr bought $11,214 worth of COLONY BANKCORP (1,009 units at $11.11) (SEC Form 4)

      4 - COLONY BANKCORP INC (0000711669) (Issuer)

      2/26/24 4:54:33 PM ET
      $CBAN
      Major Banks
      Finance
    • Shelnutt Derek bought $1,108 worth of COLONY BANKCORP (100 units at $11.08), increasing direct ownership by 1% to 8,039 units (SEC Form 4)

      4 - COLONY BANKCORP INC (0000711669) (Issuer)

      2/14/24 4:32:03 PM ET
      $CBAN
      Major Banks
      Finance

    $CBAN
    Leadership Updates

    Live Leadership Updates

    See more
    • Colony Bankcorp, Inc. Announces Retirement of Director Edward P. Loomis, Jr.

      Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today announced that Edward P. Loomis, Jr. will retire from the Board of Directors of both the Company and its wholly-owned banking subsidiary, Colony Bank, effective May 22, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250319495955/en/Colony Bankcorp announces the retirement of Director Edward P. Loomis, Jr. Loomis, an experienced executive officer, served as President and Chief Executive Officer of the Company and Colony Bank from May 2012 until his retirement in July 2018. During his tenure, he steered Colony out of the recession, adding new efficiencies and

      3/19/25 4:30:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp, Inc. Appoints Paul Joiner, III to Board of Directors

      Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today announced the appointment of Paul Joiner, III to the Board of Directors for both the Company and Colony Bank, effective March 1, 2025. Joiner brings over two decades of experience in finance, accounting, corporate leadership, and real estate investment to the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250227348679/en/Colony Bankcorp, Inc. Appoints Paul Joiner, III to Board of Directors (Photo: Business Wire) Joiner currently serves as Vice President of Finance at SASCO Chemical Group and its related entities, where he has successfully led strategic in

      2/27/25 4:30:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp Appoints Audrey Hollingsworth to Board of Directors

      Colony Bankcorp, Inc. (NASDAQ:CBAN) ("Colony" or the "Company"), the bank holding company for Colony Bank (the "Bank"), today announced the appointment of Audrey D. Hollingsworth to the Board of Directors for both the Company and Colony Bank, effective December 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221024005241/en/Colony Bankcorp Appoints Audrey D. Hollingsworth to Board of Directors (Photo: Business Wire) Hollingsworth serves as Vice President of People Services for Goodwill Industries of the Southern Rivers, a position she has held since 2018. Before joining Goodwill Industries of the Southern Rivers, Hollings

      10/24/22 8:45:00 AM ET
      $CBAN
      Major Banks
      Finance

    $CBAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $CBAN
    Financials

    Live finance-specific insights

    See more
    • Colony Bankcorp Reports First Quarter 2025 Results

      Declares Quarterly Cash Dividend of $0.1150 Per Share Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today reported financial results for the first quarter of 2025. Financial highlights are shown below. Financial Highlights: Net income was $6.6 million, or $0.38 per diluted share, for the first quarter of 2025, compared to $7.4 million, or $0.42 per diluted share, for the fourth quarter of 2024, and $5.3 million, or $0.30 per diluted share, for the first quarter of 2024. Operating net income was $6.6 million, or $0.38 of adjusted earnings per diluted share, for the first quarter of 2025, compared to $7.8 million, or $0.44 of adjusted earnings per diluted share, for the

      4/23/25 4:30:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp, Inc. Announces Date for First Quarter 2025 Earnings Release and Conference Call

      Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today announced that it will release its first quarter 2025 financial results on Wednesday, April 23, 2025, after the stock market closes. The Company will also hold a live conference call on Thursday, April 24, 2025, at 9:00 AM ET. The conference call can be accessed by dialing 1-800-549-8228 and using the Conference ID: 68027. Participants are encouraged to dial in 15 minutes prior to the call. A replay of the call will be available until Thursday, May 1, 2025, by dialing 1-888-660-6264 and entering the passcode 68027#. The financial results and investor presentation will be available under the Investor Relations section of th

      4/3/25 4:15:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp, Inc. Expands Insurance Division With Acquisition of the Ellerbee Agency

      Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today announced it has acquired The Ellerbee Agency, an Allstate appointed consumer property and casualty insurance agency. The agency will become part of Colony Insurance, the Company's wholly-owned insurance subsidiary. This acquisition expands Colony Insurance's footprint and customer base with two new office locations in Monroe, Georgia (120 W Highland Avenue) and Greensboro, Georgia (1061 Parkside Commons, Suite 201). Commenting on the announcement, T. Heath Fountain, Chief Executive Officer, said, "We are pleased to welcome The Ellerbee Agency to Colony. This acquisition supports our strategy of efficient growth and scala

      4/1/25 4:10:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp Reports First Quarter 2025 Results

      Declares Quarterly Cash Dividend of $0.1150 Per Share Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today reported financial results for the first quarter of 2025. Financial highlights are shown below. Financial Highlights: Net income was $6.6 million, or $0.38 per diluted share, for the first quarter of 2025, compared to $7.4 million, or $0.42 per diluted share, for the fourth quarter of 2024, and $5.3 million, or $0.30 per diluted share, for the first quarter of 2024. Operating net income was $6.6 million, or $0.38 of adjusted earnings per diluted share, for the first quarter of 2025, compared to $7.8 million, or $0.44 of adjusted earnings per diluted share, for the

      4/23/25 4:30:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp, Inc. Announces Date for First Quarter 2025 Earnings Release and Conference Call

      Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today announced that it will release its first quarter 2025 financial results on Wednesday, April 23, 2025, after the stock market closes. The Company will also hold a live conference call on Thursday, April 24, 2025, at 9:00 AM ET. The conference call can be accessed by dialing 1-800-549-8228 and using the Conference ID: 68027. Participants are encouraged to dial in 15 minutes prior to the call. A replay of the call will be available until Thursday, May 1, 2025, by dialing 1-888-660-6264 and entering the passcode 68027#. The financial results and investor presentation will be available under the Investor Relations section of th

      4/3/25 4:15:00 PM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp Reports Fourth Quarter 2024 Results

      Increases Quarterly Cash Dividend to $0.1150 Per Share Colony Bankcorp, Inc. (NYSE:CBAN) ("Colony" or the "Company") today reported financial results for the fourth quarter of 2024. Financial highlights are shown below. Financial Highlights: Net income increased to $7.4 million, or $0.42 per diluted share, for the fourth quarter of 2024, compared to $5.6 million, or $0.32 per diluted share, for the third quarter of 2024, and $5.6 million, or $0.32 per diluted share, for the fourth quarter of 2023. Operating net income increased to $7.8 million, or $0.44 of adjusted earnings per diluted share, for the fourth quarter of 2024, compared to $6.2 million, or $0.35 of adjusted earnings p

      1/22/25 4:30:00 PM ET
      $CBAN
      Major Banks
      Finance

    $CBAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Colony Bankcorp downgraded by Janney with a new price target

      Janney downgraded Colony Bankcorp from Buy to Neutral and set a new price target of $14.00

      2/15/23 9:05:22 AM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp downgraded by DA Davidson

      DA Davidson downgraded Colony Bankcorp from Buy to Neutral

      1/24/23 8:18:23 AM ET
      $CBAN
      Major Banks
      Finance
    • Colony Bankcorp downgraded by DA Davidson with a new price target

      DA Davidson downgraded Colony Bankcorp from Buy to Neutral and set a new price target of $16.75 from $18.00 previously

      7/22/22 8:57:13 AM ET
      $CBAN
      Major Banks
      Finance

    $CBAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $CBAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form SC 13G/A filed by Colony Bankcorp Inc. (Amendment)

      SC 13G/A - COLONY BANKCORP INC (0000711669) (Subject)

      2/14/24 3:03:09 PM ET
      $CBAN
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by Colony Bankcorp Inc. (Amendment)

      SC 13G/A - COLONY BANKCORP INC (0000711669) (Subject)

      2/13/24 5:02:36 PM ET
      $CBAN
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by Colony Bankcorp Inc. (Amendment)

      SC 13G/A - COLONY BANKCORP INC (0000711669) (Subject)

      2/8/24 3:05:36 PM ET
      $CBAN
      Major Banks
      Finance
    • CHIEF BANKING OFFICER Canup Edward G bought $7,825 worth of COLONY BANKCORP (500 units at $15.65), increasing direct ownership by 3% to 16,884 units (SEC Form 4)

      4 - COLONY BANKCORP INC (0000711669) (Issuer)

      3/14/25 4:38:22 PM ET
      $CBAN
      Major Banks
      Finance
    • New insider Joiner Paul E Iii claimed no ownership of stock in the company (SEC Form 3)

      3 - COLONY BANKCORP INC (0000711669) (Issuer)

      3/4/25 11:48:48 AM ET
      $CBAN
      Major Banks
      Finance
    • SEC Form 4 filed by Executive VP Bagwell Lee

      4 - COLONY BANKCORP INC (0000711669) (Issuer)

      2/14/25 4:39:17 PM ET
      $CBAN
      Major Banks
      Finance